Trademark Registration for Pharmaceutical | Brand Protection & Filing Support

Getting your pharmaceutical product named is not just a branding exercise, but it is shaped by Section 13 of the Trade Marks Act, 1999, which bars the registration of International Nonproprietary Names (INNs) as declared by the World Health Organization, along with names that are deceptively similar to them. Trademark in pharmaceutical industry also face a stricter deceptive similarity standard as compared to other sectors, as courts treat confusion between drug names as a genuine public health risk, not just a commercial one.

This means that your brand name needs to clear two hurdles that most industries don't face, which are avoiding resemblance to existing generic drug names and surviving stricter court review for similarity to competitor brands.

Pharmaceutical brand registration is the process where your drug or healthcare product name gets registered as a trademark under Class 5 of the Nice Classification, while taking into account the Section 13’s bar on INNs and chemical compound names. Since WHO notified INN stems, like “-olol” for beta-blockers or “-cillin” for penicillin derivatives, are considered public property, pharmaceutical companies coin brand names from the active ingredient, the disease to be treated or the affected organ, while it still keeps enough distance from the generic name.

The Supreme Court’s landmark ruling in Cadila Healthcare Ltd v Cadila Pharmaceuticals Ltd has said that even minor similarity between the drug names can be rejected because of the potential health consequences of a mix-up at the pharmacy counter. Given below are a few reasons why pharmaceutical brand protection deserves extra attention:

• Confusingly similar drug names can lead to dispensing errors, which is why courts have applied stricter tests than for most consumer goods.

• Registration gives you a legal standing that stops the competitors from launching deceptively similar names, which are common in this crowded, formula driven industry.

• A valid trademark provides Trademark Protection for years of regulatory and marketing investment in a single product name.

Pharmaceutical branding can be generally categorized into the following categories:

• Prescription drug brand names: Names for those medicines that requires a doctor’s prescription, facing the strictest similarity evaluation.

• Over-the-counter (OTC) product names: Consumer facing health and wellness product brands.

• Company and manufacturers' names: Corporate trademarks distinct from individual product names.

• Non-traditional pharma marks: Tablet shapes, colours, and packaging design, increasingly recognised alongside traditional word marks.

The choice of business structure depends on the following factors:

• Private Limited Company: This is one of the popular options for its compliance and capital requirements, associated with pharmaceutical manufacturing or distribution.

• LLP: This can be suitable for research, formulation, and distribution businesses.

• Partnership Firm: This option is sometimes used for regional pharmaceutical trading businesses.

Before you file for a pharmaceutical trademark, check the following sector-specific criteria:

• The name that you have proposed must not be identical or deceptively similar to any WHO-declared INN or chemical element or compound name under Section 13.

• Your marks must clear the deceptive similarity test that courts apply to pharmaceutical products, not only the standard Section 9/11 review.

• You will need your product’s regulatory approval process with CDSCO to run alongside, although this is separate from your trademark filing.

You must keep these documents ready before you apply for pharmaceutical brand registration:

• Identity and business incorporation documents of the applicant

• Trademark search report checking against the WHO INN database, not only the standard Registry database.

• Details of Class 5 goods or formulation that the mark will cover.

• Power of Attorney, if you are filing through a trademark agent.

Given below is the sequential procedure that can be followed for pharmaceutical Industry Trademark registration:

• Step 1: Conduct a search against the Trademark Registry and the WHO-INN database both.

• Step 2: Fill your application under Class 5, avoiding INN-derived terms

• Step 3: Respond to the examination objections, which are quite common in this sector under Section 13.

• Step 4: Clear the publication phase and the four-month opposition window.

• Step 5: Once approved, you will receive your registration certificate.

The cost for trademark registration in the pharmaceutical industry mainly depends upon your application category and how many objections your application faces during examination.

Note: Government fees vary by applicant category and are subject to change from time to time. Our consultants will confirm the current charges for your filings.

Pharmaceutical filings take longer than average, because of the additional INN related scrutiny. The initial examination typically takes a few months, which is often longer than non-pharma applications. In case objections have been raised, then responding that and addressing them may take several additional months before publication.

We at Brandregistration.co.in help you to navigate the added complexity of pharmaceutical trademark filings, right from checking your proposed name against the WHO INN database before you file, to responding to Section 13 objections with the supporting judgments that strengthen your position. Our team understands how differently this sector is treated as compared to standard consumer trademarks, and we build that into how we prepare your application from the start, that includes Trademark Hearing if it becomes necessary.